CVAC CureVac NV

USD 2.98 +0.26 ( +9.56%)
Icon

CureVac NV (CVAC) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.98

+0.26 (+9.56%)

USD 0.67B

0.83M

USD 16.00(+436.91%)

N/A

Icon

CVAC

CureVac NV (USD)
COMMON STOCK | NSD
USD 2.98
+0.26 ( +9.56%)

CureVac NV (CVAC) Annual Income Statement (USD)

CVAC Quarterly Financials (USD)

Frequently Asked Questions About CureVac NV (CVAC) Stock

CureVac NV's (CVAC) last reported annual revenue was USD 53.76 Million.

CureVac NV's (CVAC) annual revenue growth rate based on the revenue reported in the past 5 years is : 33.10%

CureVac NV's(CVAC) is not profitable as of its last reported annual financials.

The net profit margin for CureVac NV's(CVAC) from its laster reported year is -483.96%

The return on equity (ROE) for CureVac NV's(CVAC) from its last reported annual financials is : -54.30%

The return on assets (ROA) for CureVac NV's(CVAC) from its last reported annual financials is : -24.52%

The return on invested capital (ROIC) for CureVac NV's(CVAC) from its last reported annual financials is : -52.26%

The Debt to Equity ratio for CureVac NV's(CVAC) from its last reported annual financials is : 0.00%

The dividend yield for CureVac NV's(CVAC) from its laster reported year is 0.00%

CureVac NV's(CVAC) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...